Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 5
2006 1
2007 3
2008 11
2009 9
2010 6
2011 10
2012 8
2013 4
2014 9
2015 12
2016 7
2017 7
2018 6
2019 8
2020 6
2021 9
2022 10
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Modeling excess hazard with time-to-cure as a parameter.
Boussari O, Bordes L, Romain G, Colonna M, Bossard N, Remontet L, Jooste V. Boussari O, et al. Among authors: jooste v. Biometrics. 2021 Dec;77(4):1289-1302. doi: 10.1111/biom.13361. Epub 2020 Sep 12. Biometrics. 2021. PMID: 32869288
Net survival in recurrence-free colon cancer patients.
Drouillard A, Bouvier AM, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V. Drouillard A, et al. Among authors: jooste v. Cancer Epidemiol. 2019 Aug;61:124-128. doi: 10.1016/j.canep.2019.06.001. Epub 2019 Jun 15. Cancer Epidemiol. 2019. PMID: 31212224
Patterns of care and outcomes in oesophageal cancer.
Jooste V, Manfredi S, Napoleon M, Drouillard A, Marref I, Bedenne L, Faivre J, Bouvier AM. Jooste V, et al. Dig Liver Dis. 2018 Nov;50(11):1238-1243. doi: 10.1016/j.dld.2018.07.011. Epub 2018 Jul 20. Dig Liver Dis. 2018. PMID: 30126823
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, De Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L. Bonnetain F, et al. Among authors: jooste v. Eur J Cancer. 2014 Nov;50(17):2983-93. doi: 10.1016/j.ejca.2014.07.011. Epub 2014 Sep 22. Eur J Cancer. 2014. PMID: 25256896 Review.
Surgical treatment of digestive cancer in a well-defined elderly population.
Latrille A, Bouvier AM, Jooste V, Bengrine Lefevre L, Quipourt V, Moreno Lopez N, Facy O. Latrille A, et al. Among authors: jooste v. Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101857. doi: 10.1016/j.clinre.2021.101857. Epub 2021 Dec 25. Clin Res Hepatol Gastroenterol. 2022. PMID: 34963649
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.
Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. Bellera CA, et al. Among authors: jooste v. Ann Oncol. 2015 May;26(5):865-872. doi: 10.1093/annonc/mdu360. Epub 2014 Jul 28. Ann Oncol. 2015. PMID: 25070543 Free article. Review.
120 results